| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/15/2011 | US7888356 Antibiotics containing borinic acid complexes and methods of use |
| 02/15/2011 | US7888327 Methods of using immunostimulatory nucleic acid molecules to treat allergic conditions |
| 02/15/2011 | US7888315 Use of aspartic proteases in cosmetics and therapeutics |
| 02/15/2011 | US7888114 encoding a Herpesviridae thymidine kinase enzyme comprising one or more mutations; for gene therapy, cancer |
| 02/15/2011 | US7888091 Fusion proteins having thymidine kinase and guanylate kinase activities |
| 02/15/2011 | US7887850 Method for reducing pathogens in the gastrointestinal tract of poultry and other food animals |
| 02/15/2011 | US7887845 Antiviral compositions |
| 02/15/2011 | US7887816 Attenuated microorganisms for the treatment of infection |
| 02/15/2011 | CA2628883C Novel 3'-modified oligonucleotide derivatives |
| 02/15/2011 | CA2617000C Methods for preparing nevirapine hemihydrate and an aqueous suspension thereof |
| 02/15/2011 | CA2480562C 5-substituted 1,1-dioxo-1,2,5-thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 02/15/2011 | CA2446864C Inhibitors of src and other protein kinases |
| 02/15/2011 | CA2444895C Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 02/15/2011 | CA2416757C Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 02/15/2011 | CA2407046C Immunoregulator |
| 02/15/2011 | CA2373554C Process for the preparation and purification of thiol-containing maytansinoids |
| 02/15/2011 | CA2347084C Hepatitis a vaccines |
| 02/15/2011 | CA2311389C Antimicrobial peptides |
| 02/15/2011 | CA2200691C Broadly reactive opsonic antibodies reactive with common staphylococcal antigens |
| 02/15/2011 | CA2192235C Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 02/11/2011 | WO2011018793A1 A novel standardized composition, method of manufacture and use in the resolution of rna virus infection |
| 02/11/2011 | CA2721040A1 Procyanidin extracts of cinnamon, litchi and arachis useful in the treatment of retroviral infections |
| 02/10/2011 | WO2011017389A1 Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv |
| 02/10/2011 | WO2011017125A1 Trisubstituted boron-containing molecules |
| 02/10/2011 | WO2011017079A1 Process for the preparation and purification of etravirine and intermediates thereof |
| 02/10/2011 | WO2011016749A1 Combined anti-tuberculosis composition |
| 02/10/2011 | WO2011016527A1 Hydroxyl radical generator, antiviral material using hydroxyl radical generator, and method for generating hydroxyl radicals |
| 02/10/2011 | WO2011016459A1 Thienooxazepine derivative |
| 02/10/2011 | WO2011016432A1 Immune balance-regulating agent |
| 02/10/2011 | WO2011015658A1 Bis-benzimidazole derivatives as hepatitis c virus inhibitors |
| 02/10/2011 | WO2011015657A1 Phenyl ethynyl derivatives as hepatitis c virus inhibitors |
| 02/10/2011 | WO2011015656A2 Composition for treating hbv infection |
| 02/10/2011 | WO2011015641A1 Novel viral replication inhibitors |
| 02/10/2011 | WO2011015121A1 Anti-idiotypic monoclonal antibody against envelope protein vp28 of shrimp white spot syndrome virus and the preparation method thereof |
| 02/10/2011 | WO2011015037A1 Antiviral compounds and methods of making and using there of cross reference to related applications |
| 02/10/2011 | WO2011014990A1 Azacyclohexapeptide or its pharmaceutical acceptable salt, preparing method and use thereof |
| 02/10/2011 | WO2010028798A8 Multivalent antibodies |
| 02/10/2011 | WO2010012045A8 Influenza vaccines |
| 02/10/2011 | US20110035817 Siva 3, its preparation and use |
| 02/10/2011 | US20110035232 Methods of treating hepatic encephalopathy |
| 02/10/2011 | US20110034566 Long term drug delivery devices with polyurethane based polymers and their manufacture |
| 02/10/2011 | US20110034557 Antimicrobial compositions and uses thereof |
| 02/10/2011 | US20110034547 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 02/10/2011 | US20110034545 Double-stranded lipid-modified rna having high rna interference effect |
| 02/10/2011 | US20110034537 Compositions and methods for inhibiting expression of cd45 gene |
| 02/10/2011 | US20110034528 Elansolids, Novel Natural Metabolites of Flexibacter and Antibiotically Active Derivatives Thereof |
| 02/10/2011 | US20110034524 Hemi-fumarate salt of a 1,3,4-thiadiazolyl derivative as modulator of the sphingosine 1-phosphate receptor |
| 02/10/2011 | US20110034499 Spiroindolines as modulators of chemokine receptors |
| 02/10/2011 | US20110034497 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| 02/10/2011 | US20110034495 Method of Modulating Stress-Activated Protein Kinase System |
| 02/10/2011 | US20110034489 Solid dosage forms of hiv protease inhibitors |
| 02/10/2011 | US20110034487 Cxcr3 antagonists |
| 02/10/2011 | US20110034478 Oral Pharmaceutical Compositions in a Solid Dispersion Comprising Preferably Posaconazole and HPMCAs |
| 02/10/2011 | US20110034463 Type iii secretion inhibitors, analogs and uses thereof |
| 02/10/2011 | US20110034458 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 02/10/2011 | US20110034449 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/10/2011 | US20110034443 Uses of substituted imidazoheterocycles |
| 02/10/2011 | US20110034441 Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof |
| 02/10/2011 | US20110034438 Structural mimetics of proline-rich peptides and the pharmaceutical use thereof |
| 02/10/2011 | US20110034430 Phospholipid Gel Compositions for Drug Delivery and Methods of Treating Conditions Using Same |
| 02/10/2011 | US20110034405 Novel aminoglycoside antibiotics, process for producing the same, and pharmaceutical use thereof |
| 02/10/2011 | US20110034395 Compositions and methods of inhibiting apoptosis |
| 02/10/2011 | US20110034370 Bis-met histones |
| 02/10/2011 | US20110033566 Anti-bacterial composition comprising extract from barks of Alnus pendula Matsum |
| 02/10/2011 | US20110033556 Natural Pharmaceutical Preparations for Increasing Albumin |
| 02/10/2011 | US20110033526 Pharmaceutical composition of antibiotics and prebiotics for preventing and treating dysbiosis during antibacterial therapy |
| 02/10/2011 | US20110033522 Reagents for inducing an immune response |
| 02/10/2011 | US20110033520 Antimicrobial Nanostructured Hydrogel Web Containing Silver |
| 02/10/2011 | US20110033500 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb-neisseria meningitidis |
| 02/10/2011 | US20110033499 Anti-viral nutraceutical |
| 02/10/2011 | US20110033497 Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus |
| 02/10/2011 | US20110033495 Methods and compositions for reducing the impact of enteric diseases |
| 02/10/2011 | US20110033494 Anti-Infective Agents and Uses Thereof |
| 02/10/2011 | US20110033491 Multicomponent meningococcal vaccine |
| 02/10/2011 | US20110033490 Compositions and methods for diagnosing and/or treating influenza infection |
| 02/10/2011 | US20110033489 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 02/10/2011 | US20110033487 Vaccines and diagnostics for the ehrlichioses |
| 02/10/2011 | US20110033485 Analogues of glycolipids useful as immunoadjuvants |
| 02/10/2011 | US20110033476 Compositions and methods for the therapy and diagnosis of influenza |
| 02/10/2011 | US20110033475 Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| 02/10/2011 | US20110033473 Anti influenza antibodies and uses thereof |
| 02/10/2011 | US20110033469 Leukotriene b4 binding soluble lipocalin receptor from ixodes ricinus |
| 02/10/2011 | US20110033462 Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (jev) and their use |
| 02/10/2011 | US20110033454 Methods For Treating Diseases Using Antibodies to Aminophospolipids |
| 02/10/2011 | US20110033450 Antibody Against Anthrax Toxins |
| 02/10/2011 | US20110033449 Human immune therapies using a CD27 agonist alone or in combination with other immune modulators |
| 02/10/2011 | US20110033448 Inhibitors of LL-37 Mediated Immune Reactivity to Self Nucleic Acids |
| 02/10/2011 | US20110033446 Treatment of HIV-1-infected individuals to reduce risk of coronary artery disease and suppress virus replication |
| 02/10/2011 | US20110033442 Targets, including yap1, for antifungal drug discovery and therapy |
| 02/10/2011 | US20110033439 Targeted antimicrobials and related compositions, methods and systems |
| 02/10/2011 | US20110033437 Debridement Method Using Topical Nitric Oxide Donor Devices and Compositions |
| 02/10/2011 | US20110033435 Composition of activated CD4 cells |
| 02/10/2011 | US20110033429 Inducible Gene Expression |
| 02/10/2011 | US20110033422 Treatments for flaviviridae virus infection |
| 02/10/2011 | US20110033421 Methods related to immunostimulatory nucleic acid-induced interferon |
| 02/10/2011 | US20110033420 Macrocyclic compounds as hepatitis c virus inhibitors |
| 02/10/2011 | US20110033417 2,3-substituted indole derivatives for treating viral infections |
| 02/10/2011 | US20110033406 Preserved product; and preservative composition |
| 02/10/2011 | US20110033389 Modified antibodies for passive immunotherapy |
| 02/10/2011 | US20110033378 Cysteine Engineered Antibodies For Site-Specific Conjugation |